HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:


Markets in Asia followed Wall Street higher today as fears about North Korea and damage from Hurricane Irma abated. A stronger US dollar saw both the Nikkei and the ASX make steady gains, though there was weakness elsewhere. The Hang Seng and the SGX declined. “Profit taking could be one reason behind this technical pullback. Technically, the Hang Seng Index is facing strong selling pressure at 28,000 points – a psychological resistance level,” explained Margaret Yang Yan at CMC Markets in Singapore. Chinese markets traded more or less flat.
Sisram Medical, a Israeli subsidiary of Shanghai Fosun Pharmaceutical, and which manufactures medical aesthetics devices, has priced its HK$977 million (US$125 million) IPO on the Hong Kong Stock Exchange at the low end of guidance. It sold 110 million shares or around 25% of its total share capital at HK$8.88 per share. The first day of trading is 19 September. Joint sponsors are CICC and Jefferies.
Hong Kong-headquartered healthcare services company UMP Healthcare has announced that the public float of the company has fallen below the minimum prescribed percentage of 25% of the total issued share capital. “The company undertakes to procure that appropriate steps will be taken to ensure restoration of the minimum prescribed percentage as soon as reasonably practicable in accordance with the listing rules,” it said, though it admitted that it has not yet determined any definitive proposal.
In a scandal which has dominated the Indonesian press since the weekend, shares in Indonesian hospital operator Mitra Keluarga have crashed 5.2% this week after a baby girl died when she was denied paediatric care at one of its hospitals. Her parents claim that it is because they had been unable to pay the hospital’s upfront treatment fees. Its shares were last see flat at Rp2,000 (US$0.15).
As part of an internal reorganisation, IHH Healthcare, Asia’s largest healthcare company, has merged its Bulgarian subsidiaries, Acibadem City Clinic EAD and Tokushukai-Sofia. IHH said that this was to streamline Acibadem group’s structure and management, and that it would have no material effect on IHH’s earnings, net assets or gearing.
HLIB Research remains cool on medical rubber glove manufacturer Hartalega Holdings after a visit to its new manufacturing complex in Sepang. “Whilst we like Hartalega for its leadership position in the nitrile glove market; high ROE and net profit margins amidst a favourable operating environment, we believe the share price has run its course and these fundamentals are fully reflected at the current share price,” writes analyst Sheikh Abdullah. He maintains his “hold” and target price of M$7.04 (US$1.67). Hartalega shares were last seen down 2.46% at M$6.54.
Maybank Kim Eng is positive on women’s healthcare specialist Singapore O&G (SOG) in a detailed new report on the unrated company. “Based on consensus estimates, SOG trades at 24x/20x FY17E/FY18E P/E. This is at a slight discount of 8%/20% vs Singapore peers’ PE of 26x/25x. On the other hand, SOG offers a respectable 4.0% dividend yield for FY17E, which is the second-highest among Singapore’s peers, which generate 0.5%-5.0% dividend yield,” writes analyst John Cheong.
Retirement village operator Arvida is to acquire three villages in New Zealand – Mary Doyle Lifecare, Strathallan Lifecare and 50% of Village at the Park Lifecare – from Hurst Lifecare for approximately NZ$106 million (US$76.7 million).
Oceania Healthcare, New Zealand’s third largest retirement village operator, has acquired a site adjacent to its Eden facility in Mt Eden, Auckland. Financial terms have not been disclosed.
Golden Equator, a group of five independently managed companies based in Singapore, has launched the Korea-Singapore Healthcare Incubator together with Korean regulatory and clinical research provider C&R Healthcare Global. The incubator will help 10 to15 Korean companies expand into Singapore and southeast Asia over the next few months.
In people news, Australian medical software developer Medadvisor has appointed two regional advisors to accelerate its global expansion strategy. Jamal Butt and Keith Kiarsis will lead MedAdvisor’s market entry strategies into the UK and US, respectively.
In our must-read for the day, Albert Wong argues that biomedical technology should not be ignored and explains how the Hong Kong Science and Technology Parks Corporation can support it.

Posted on: 13/09/2017 UTC+08:00


Sleep-related breathing disorder medtech company SomnoMed has raised A$4.5 million (US$3.5 million) in the retail component of its A$10.4 million capital raising.
Beijing-based paediatric healthcare provider New Century Healthcare has been cleared by the Health and Family Planning Commission of Chaoyang District in Beijing to establish a 1,300 square-meter paediatric clinic.
Wattanapat Hospital Trang is planning to build a new Bt425 million (US$13.6 million) hospital in Samui.
Following an investigation by the Australian Competition and Consumer Commission, criminal charges have been laid against the healthcare equipment company Country Care Group, its managing director, Robert Hogan, and a former employee, Cameron Harrison.
Shares in regenerative med-tech group Avita Medical jumped 3.4% yesterday after the group announced the start of a randomised, controlled clinical trial of its burn treatment funded by the China National Health and Family Planning Commission.
Korea’s Ssangyong Engineering & Construction and Daewoo Engineering & Construction, together with Catalist-listed Koh Brothers Eco Engineering have been awarded the W788 billion (US$735.8 million) Woodlands Health Campus (WHC) development project in Singapore by the ministry of health.
Australian dental care chain 1300 Smiles is to acquire a dental practice in Buderim, Queensland. The practice provides a full range of dental services including cosmetic and orthodontic to the Sunshine Coast community.
Sydney-headquartered wireless urinary incontinence technology company Simavita has secured commitments to raise A$1.4 million (US$1.1 million) by way of unsecured convertible notes.


Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman, and Matt Zafra, engagement manager, health & life sciences, Oliver Wyman, look at the four themes that are going to dominate healthcare this year.
It can sometimes seem that the healthcare sector is a guaranteed money spinner for investors. It has everything going for it. Societal demands and demographics make it a sure thing, say enthusiasts. And investors have become used to the fact that everything it touches turns to gold.
Yesterday’s stock price fall for Ramsay Health Care was not entirely unexpected. Shares in Australia’s largest private hospital operator dropped 5.75% to A$63.90 (US$49.81) after it revealed distinctly unimpressive first half figures.
Susann Roth, senior social development specialist, Asian Development Bank, gives one way how health risks can be lowered at Special Economic Zones.
Nicole Hill, global director of healthcare at ALE, has a goal to make everyone and everything in healthcare connected. She explains how healthcare is entering a second wave of digitisation in Asia.
There is a simple reason why healthcare stocks on the SGX rose today. Yesterday’s budget was focused firmly on healthcare. Finance minister Heng Swee Keat announced not just an additional S$10.2 billion (US$7.8 million) for healthcare over the next year, he made clear that he was committed to the sector.
A new paper from KPMG looks at the disconnect between consumer expectations and the current healthcare experience of patients in Australia.
Gan Kim Yong, Singapore’s minister for health, explains why integrated care is important in the context of an ageing population.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices